Yahoo

OMRON (TSE:6645) Slides On Valuation Concerns, Is The Stock Overvalued?

OMRON stock performance snapshot

OMRON (TSE:6645) has drawn fresh attention after recent price weakness, with the share price down about 3% over the past day and roughly 16% over the past month.

Returns over the past year remain positive, while the past 3 months show a mid single digit decline. This gives investors a mixed picture of how the stock has traded across different time frames.

Recent trading paints a picture of fading momentum for OMRON, with the share price sliding in the short term even as the year to date share price return remains positive and the 1 year total shareholder return of 22.42% contrasts with weaker 3 and 5 year total shareholder returns.

Compare OMRON's recent pullback with other robotics and automation plays by scanning our hand picked 95 robotics and automation stocks for potential alternatives on your watchlist.

After a sharp pullback, and with a ¥5,330 price that still sits well below analyst targets but above one intrinsic estimate, where does fair value for OMRON really land within that range?

Price-to-Earnings of 24.1x: Is it justified for OMRON?

On a simple snapshot, OMRON trades on a P/E of 24.1x, which makes the current ¥5,330 share price look expensive compared with both its industry and an estimated fair level.

The P/E ratio links what you pay today for each unit of current earnings. For a business like OMRON that operates across industrial automation, healthcare devices, social systems, and data solutions, investors often focus on P/E because earnings power is central to how these segments are judged.

Forecasts point to earnings growth of 15.16% per year and 32.9% earnings expansion over the past year. That sets an earnings backdrop that some investors may see as supportive of a richer multiple. However, the forecast return on equity of 7.5% and a low current return on equity of 5.4% suggest profitability is not especially high compared to many quality-focused stocks.

The gap is clear when lined up against the JP Electronic industry average P/E of 15x and an estimated fair P/E of 21.9x. The market is paying a premium to the sector and even to the fair ratio. This signals that expectations embedded in the current price are already demanding and could leave less room for error if growth or profitability delivery softens.

Explore the SWS fair ratio for OMRON.

Result: Price-to-Earnings of 24.1x (OVERVALUED)

Still, the wide gap between OMRON's recent earnings power and its lower 3 and 5 year total shareholder returns could reset sentiment if profitability or automation demand disappoints.

Find out about the key risks to this OMRON narrative .

Another view on OMRON's value

While the P/E ratio presents OMRON as expensive, the SWS DCF model points to an intrinsic value of ¥4,169.02 compared with the current ¥5,330 share price. That gap suggests the stock screens as overvalued on cash flow assumptions, so which lens should carry more weight for you?

Look into how the SWS DCF model arrives at its fair value.

6645 Discounted Cash Flow as at Oct 2026
6645 Discounted Cash Flow as at Oct 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out OMRON for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 14 high quality undervalued stocks . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals around OMRON's valuation and future potential do not have to leave you on the fence. Move quickly, examine the numbers yourself, and then weigh up the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond OMRON?

If OMRON has raised more questions than answers for your portfolio, use that curiosity as a springboard to refresh your watchlist with new candidates.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include 6645.T .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: